Загрузка...
Itraconazole Increases Ibrutinib Exposure 10‐Fold and Reduces Interindividual Variation—A Potentially Beneficial Drug‐Drug Interaction
The oral bioavailability of ibrutinib is low and variable, mainly due to extensive first‐pass metabolism by cytochrome P450 (CYP) 3A4. The unpredictable exposure can compromise its safe and effective dosing. We examined the impact of itraconazole on ibrutinib pharmacokinetics. In a randomized crosso...
Сохранить в:
| Опубликовано в: : | Clin Transl Sci |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7070818/ https://ncbi.nlm.nih.gov/pubmed/31664782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12716 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|